Clinical trials
Withdrawn Phase 2 trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 2 |
| Catholic University of the Sacred Heart | 2 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2 |
| National Cancer Institute, Naples | 2 |
| Arrowhead Pharmaceuticals | 1 |
| Azienda Ospedaliero-Universitaria di Parma | 1 |
| Bayer | 1 |
| CSL Behring | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 5 |
| Melanoma | 3 |
| Lung Neoplasms | 2 |
| Myelodysplastic Syndromes | 2 |
| Ovarian Neoplasms | 2 |
| Adenoviridae Infections | 1 |
| Anemia | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Angina, Stable | 1 |
| Anterior Wall Myocardial Infarction | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.